Fentanyl is a synthetic opioid developed for medical use in anaesthesia and severe pain management. In Australia it is prescribed in forms such as transdermal patches and is used in hospitals under strict control. It is commonly described as around 100 times more potent than morphine, which is exactly why it is valuable in medicine and dangerous outside it.
Outside medical settings, fentanyl reaches people through diverted pharmaceutical products and through illicitly manufactured powders, sometimes mixed into or sold as other drugs. Overseas, illicit fentanyl has driven a sustained overdose crisis. In Australia, health authorities have issued alerts about fentanyl and related synthetic opioids, including nitazenes, being detected in the illicit drug supply.
For organisations, the concern is less about volume and more about potency. A small quantity of fentanyl on a surface can matter in a way that the same quantity of a stimulant would not. That makes accurate, low level measurement central to any decision about whether equipment, vehicles or premises are safe.
Fentanyl analysis is most often requested by police, ambulance and fire services, corrections and custody facilities, hygienists assessing workplaces, and property owners and remediators where fentanyl products are known or suspected to have been used or stored.